犬アトピー性皮膚炎の世界市場 2022-2026Global Canine Atopic Dermatitis Market 2022-2026 犬のアトピー性皮膚炎の世界市場2022-2026年 Technavioは犬のアトピー性皮膚炎市場を監視しており、2022年から2026年の間に3億1937万ドルの成長が見込まれ、予測期間中にCAGR7.75%で進行しています。当レポート... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー犬のアトピー性皮膚炎の世界市場2022-2026年Technavioは犬のアトピー性皮膚炎市場を監視しており、2022年から2026年の間に3億1937万ドルの成長が見込まれ、予測期間中にCAGR7.75%で進行しています。当レポートでは、犬のアトピー性皮膚炎市場の全体分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを提供しています。 現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、ペットのヒューマニゼーションが進み、疾病予防やペット保険に関する意識が高まっていることが要因となっています。また、ペットのヒューマニゼーションが進むことで、市場の成長も促進されると予想されます。 犬のアトピー性皮膚炎市場の分析には、製品セグメントと地理的状況が含まれます。 Technavioの犬アトピー性皮膚炎市場は、以下のように区分されています。 製品別 - 抗ヒスタミン剤 - グルココルチコイド - 黄体ホルモン化合物 - その他 地域別状況 - 北米 - ヨーロッパ - アジア - 列 本調査では、今後数年間の犬アトピー性皮膚炎市場の成長を促進する主要な理由の一つとして、動物のアレルギー性疾患治療の重要性が高まっていることを挙げています。 Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な図を提示します。犬のアトピー性皮膚炎市場に関する当レポートの対象領域は以下の通りです。 - 犬のアトピー性皮膚炎市場のサイジング - 犬アトピー性皮膚炎市場予測 - 犬アトピー性皮膚炎市場の産業分析 Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Bioceltix Spolka Akcyjna, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc, Novartis AG, Toray Industries Inc, Vetoquinol UK Ltd, Vimian Group AB, Virbac, Zoetis Incなどの複数の犬アトピー性皮膚炎市場の主要ベンダーに関する詳細分析を提供します。また、犬アトピー性皮膚炎市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。 本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/canine-atopic-dermatitis-market-industry-analysis をご覧ください。 Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。また、業界の主要な影響力を持つ人物を特定することで、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。 目次• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis o Research and development (R&D) and drug discovery o Integration and product development o Manufacturing o Outbound logistics o Marketing and sales o Support services o Innovation • Market Sizing o Market segment analysis o Market size 2021 o Market definition o Market outlook: Forecast for 2021 - 2026 o Estimating growth rates for emerging and high-growth markets o Estimating growth rates for mature markets • Five Forces Analysis o Five Forces Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o Antihistamines - Market size and forecast 2021-2026 o Glucocorticoids - Market size and forecast 2021-2026 o Progestational compounds - Market size and forecast 2021-2026 o Others - Market size and forecast 2021-2026 o Market opportunity by Product • Customer landscape o Overview • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape • Drivers, Challenges, and Trends o Market drivers o Increase in pet humanization o Rising awareness about disease prevention and pet insurance o Rising importance of treatment of allergic conditions in animals o Market challenges o Stringent global regulatory requirements o Poor patient adherence o Increasing resistance for antibiotics o Market trends o Increase in M&A o Increasing drug administration in livestock to propel drugs o Rising number of veterinary drug stores • Vendor Landscape o Overview o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Bioceltix Spolka Akcyjna o Ceva Sante Animale o Dechra Pharmaceuticals Plc o Elanco Animal Health Inc. o Novartis AG o Toray Industries Inc. o Vetoquinol UK Ltd. o Vimian Group AB o Virbac o Zoetis Inc. • Appendix o Scope of the report o Market definition o Objectives o Notes and Caveats o Currency conversion rates for US$ o Research Methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Product - Market share 2021-2026 (%) • 22: Comparison by Product • 23: Antihistamines - Market size and forecast 2021-2026 ($ million) • 24: Antihistamines - Year-over-year growth 2021-2026 (%) • 25: Glucocorticoids - Market size and forecast 2021-2026 ($ million) • 26: Glucocorticoids - Year-over-year growth 2021-2026 (%) • 27: Progestational compounds - Market size and forecast 2021-2026 ($ million) • 28: Progestational compounds - Year-over-year growth 2021-2026 (%) • 29: Others - Market size and forecast 2021-2026 ($ million) • 30: Others - Year-over-year growth 2021-2026 (%) • 31: Market opportunity by Product • 32: Customer landscape • 33: Market share By Geographical Landscape 2021-2026 (%) • 34: Geographic comparison • 35: North America - Market size and forecast 2021-2026 ($ million) • 36: North America - Year-over-year growth 2021-2026 (%) • 37: Europe - Market size and forecast 2021-2026 ($ million) • 38: Europe - Year-over-year growth 2021-2026 (%) • 39: Asia - Market size and forecast 2021-2026 ($ million) • 40: Asia - Year-over-year growth 2021-2026 (%) • 41: ROW - Market size and forecast 2021-2026 ($ million) • 42: ROW - Year-over-year growth 2021-2026 (%) • 43: Key leading countries • 44: Market opportunity By Geographical Landscape ($ million) • 45: Impact of drivers and challenges • 46: Vendor landscape • 47: Landscape disruption • 48: Industry risks • 49: Vendors covered • 50: Market positioning of vendors • 51: Bioceltix Spolka Akcyjna - Overview • 52: Bioceltix Spolka Akcyjna - Product and service • 53: Bioceltix Spolka Akcyjna - Key offerings • 54: Bioceltix Spolka Akcyjna - Key customers • 55: Bioceltix Spolka Akcyjna - Segment focus • 56: Ceva Sante Animale - Overview • 57: Ceva Sante Animale - Product and service • 58: Ceva Sante Animale - Key offerings • 59: Ceva Sante Animale - Key customers • 60: Ceva Sante Animale - Segment focus • 61: Dechra Pharmaceuticals Plc - Overview • 62: Dechra Pharmaceuticals Plc - Business segments • 63: Dechra Pharmaceuticals Plc - Key offerings • 64: Dechra Pharmaceuticals Plc - Key customers • 65: Dechra Pharmaceuticals Plc - Segment focus • 66: Elanco Animal Health Inc. - Overview • 67: Elanco Animal Health Inc. - Product and service • 68: Elanco Animal Health Inc. - Key offerings • 69: Elanco Animal Health Inc. - Key customers • 70: Elanco Animal Health Inc. - Segment focus • 71: Novartis AG - Overview • 72: Novartis AG - Business segments • 73: Novartis AG - Key offerings • 74: Novartis AG - Key customers • 75: Novartis AG - Segment focus • 76: Toray Industries Inc. - Overview • 77: Toray Industries Inc. - Business segments • 78: Toray Industries Inc. - Key offerings • 79: Toray Industries Inc. - Key customers • 80: Toray Industries Inc. - Segment focus • 81: Vetoquinol UK Ltd. - Overview • 82: Vetoquinol UK Ltd. - Product and service • 83: Vetoquinol UK Ltd. - Key offerings • 84: Vetoquinol UK Ltd. - Key customers • 85: Vetoquinol UK Ltd. - Segment focus • 86: Vimian Group AB - Overview • 87: Vimian Group AB - Product and service • 88: Vimian Group AB - Key offerings • 89: Vimian Group AB - Key customers • 90: Vimian Group AB - Segment focus • 91: Virbac - Overview • 92: Virbac - Business segments • 93: Virbac - Key offerings • 94: Virbac - Key customers • 95: Virbac - Segment focus • 96: Zoetis Inc. - Overview • 97: Zoetis Inc. - Business segments • 98: Zoetis Inc. - Key offerings • 99: Zoetis Inc. - Key customers • 100: Zoetis Inc. - Segment focus • 101: Currency conversion rates for US$ • 102: Research Methodology • 103: Validation techniques employed for market sizing • 104: Information sources • 105: List of abbreviations
SummaryGlobal Canine Atopic Dermatitis Market 2022-2026 Table of Contents• Executive Summaryo Market Overview • Market Landscape o Market ecosystem o Value chain analysis o Research and development (R&D) and drug discovery o Integration and product development o Manufacturing o Outbound logistics o Marketing and sales o Support services o Innovation • Market Sizing o Market segment analysis o Market size 2021 o Market definition o Market outlook: Forecast for 2021 - 2026 o Estimating growth rates for emerging and high-growth markets o Estimating growth rates for mature markets • Five Forces Analysis o Five Forces Summary o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition • Market Segmentation by Product o Market segments o Comparison by Product o Antihistamines - Market size and forecast 2021-2026 o Glucocorticoids - Market size and forecast 2021-2026 o Progestational compounds - Market size and forecast 2021-2026 o Others - Market size and forecast 2021-2026 o Market opportunity by Product • Customer landscape o Overview • Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2021-2026 o Europe - Market size and forecast 2021-2026 o Asia - Market size and forecast 2021-2026 o ROW - Market size and forecast 2021-2026 o Key leading countries o Market opportunity By Geographical Landscape • Drivers, Challenges, and Trends o Market drivers o Increase in pet humanization o Rising awareness about disease prevention and pet insurance o Rising importance of treatment of allergic conditions in animals o Market challenges o Stringent global regulatory requirements o Poor patient adherence o Increasing resistance for antibiotics o Market trends o Increase in M&A o Increasing drug administration in livestock to propel drugs o Rising number of veterinary drug stores • Vendor Landscape o Overview o Landscape disruption • Vendor Analysis o Vendors covered o Market positioning of vendors o Bioceltix Spolka Akcyjna o Ceva Sante Animale o Dechra Pharmaceuticals Plc o Elanco Animal Health Inc. o Novartis AG o Toray Industries Inc. o Vetoquinol UK Ltd. o Vimian Group AB o Virbac o Zoetis Inc. • Appendix o Scope of the report o Market definition o Objectives o Notes and Caveats o Currency conversion rates for US$ o Research Methodology o List of abbreviations Exhibits • 1: Key Finding 1 • 2: Key Finding 2 • 3: Key Finding 3 • 4: Key Finding 5 • 5: Key Finding 6 • 6: Key Finding 7 • 7: Key Finding 8 • 8: Parent market • 9: Market characteristics • 10: Offerings of vendors included in the market definition • 11: Market segments • 12: Global - Market size and forecast 2021 - 2026 ($ million) • 13: Global market: Year-over-year growth 2021 - 2026 (%) • 14: Five forces analysis 2021 & 2026 • 15: Bargaining power of buyers • 16: Bargaining power of suppliers • 17: Threat of new entrants • 18: Threat of substitutes • 19: Threat of rivalry • 20: Market condition - Five forces 2021 • 21: Product - Market share 2021-2026 (%) • 22: Comparison by Product • 23: Antihistamines - Market size and forecast 2021-2026 ($ million) • 24: Antihistamines - Year-over-year growth 2021-2026 (%) • 25: Glucocorticoids - Market size and forecast 2021-2026 ($ million) • 26: Glucocorticoids - Year-over-year growth 2021-2026 (%) • 27: Progestational compounds - Market size and forecast 2021-2026 ($ million) • 28: Progestational compounds - Year-over-year growth 2021-2026 (%) • 29: Others - Market size and forecast 2021-2026 ($ million) • 30: Others - Year-over-year growth 2021-2026 (%) • 31: Market opportunity by Product • 32: Customer landscape • 33: Market share By Geographical Landscape 2021-2026 (%) • 34: Geographic comparison • 35: North America - Market size and forecast 2021-2026 ($ million) • 36: North America - Year-over-year growth 2021-2026 (%) • 37: Europe - Market size and forecast 2021-2026 ($ million) • 38: Europe - Year-over-year growth 2021-2026 (%) • 39: Asia - Market size and forecast 2021-2026 ($ million) • 40: Asia - Year-over-year growth 2021-2026 (%) • 41: ROW - Market size and forecast 2021-2026 ($ million) • 42: ROW - Year-over-year growth 2021-2026 (%) • 43: Key leading countries • 44: Market opportunity By Geographical Landscape ($ million) • 45: Impact of drivers and challenges • 46: Vendor landscape • 47: Landscape disruption • 48: Industry risks • 49: Vendors covered • 50: Market positioning of vendors • 51: Bioceltix Spolka Akcyjna - Overview • 52: Bioceltix Spolka Akcyjna - Product and service • 53: Bioceltix Spolka Akcyjna - Key offerings • 54: Bioceltix Spolka Akcyjna - Key customers • 55: Bioceltix Spolka Akcyjna - Segment focus • 56: Ceva Sante Animale - Overview • 57: Ceva Sante Animale - Product and service • 58: Ceva Sante Animale - Key offerings • 59: Ceva Sante Animale - Key customers • 60: Ceva Sante Animale - Segment focus • 61: Dechra Pharmaceuticals Plc - Overview • 62: Dechra Pharmaceuticals Plc - Business segments • 63: Dechra Pharmaceuticals Plc - Key offerings • 64: Dechra Pharmaceuticals Plc - Key customers • 65: Dechra Pharmaceuticals Plc - Segment focus • 66: Elanco Animal Health Inc. - Overview • 67: Elanco Animal Health Inc. - Product and service • 68: Elanco Animal Health Inc. - Key offerings • 69: Elanco Animal Health Inc. - Key customers • 70: Elanco Animal Health Inc. - Segment focus • 71: Novartis AG - Overview • 72: Novartis AG - Business segments • 73: Novartis AG - Key offerings • 74: Novartis AG - Key customers • 75: Novartis AG - Segment focus • 76: Toray Industries Inc. - Overview • 77: Toray Industries Inc. - Business segments • 78: Toray Industries Inc. - Key offerings • 79: Toray Industries Inc. - Key customers • 80: Toray Industries Inc. - Segment focus • 81: Vetoquinol UK Ltd. - Overview • 82: Vetoquinol UK Ltd. - Product and service • 83: Vetoquinol UK Ltd. - Key offerings • 84: Vetoquinol UK Ltd. - Key customers • 85: Vetoquinol UK Ltd. - Segment focus • 86: Vimian Group AB - Overview • 87: Vimian Group AB - Product and service • 88: Vimian Group AB - Key offerings • 89: Vimian Group AB - Key customers • 90: Vimian Group AB - Segment focus • 91: Virbac - Overview • 92: Virbac - Business segments • 93: Virbac - Key offerings • 94: Virbac - Key customers • 95: Virbac - Segment focus • 96: Zoetis Inc. - Overview • 97: Zoetis Inc. - Business segments • 98: Zoetis Inc. - Key offerings • 99: Zoetis Inc. - Key customers • 100: Zoetis Inc. - Segment focus • 101: Currency conversion rates for US$ • 102: Research Methodology • 103: Validation techniques employed for market sizing • 104: Information sources • 105: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートTechNavio 社の最新刊レポート本レポートと同じKEY WORD(canine)の最新刊レポート
よくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/22 10:26 151.74 円 164.56 円 199.74 円 |